US FDA’s Novel Approvals Peak Near Year-End, Analysis Of Last Decade Suggests

 
• By Bridget Silverman

The Center for Drug Evaluation and Research’s novel approvals concentrated in August, November, and December, while January and June were the slowest months, according to a Pink Sheet analysis of 2014-2023 data.

statistical analysis
January and June are slow months for NME approvals. • Source: Shutterstock

More from Approvals

More from Product Reviews